BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9646643)

  • 1. Radioimmunolocalization of primary and metastatic breast cancer.
    Baum RP; Brümmendorf TH
    Q J Nucl Med; 1998 Mar; 42(1):33-42. PubMed ID: 9646643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
    Goldenberg DM; Wegener W
    Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging in breast cancer.
    Schuster DM; Halkar RK
    Radiol Clin North Am; 2004 Sep; 42(5):885-908, vi-vii. PubMed ID: 15337423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Positron emission tomography (PET) in diagnosis of breast carcinoma].
    Ivancevic V
    Zentralbl Chir; 1998; 123 Suppl 5():53-6. PubMed ID: 10063574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer. Radiologic staging.
    Thoeni RF
    Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer imaging with radiolabeled antibodies.
    Goldenberg DM; Nabi HA
    Semin Nucl Med; 1999 Jan; 29(1):41-8. PubMed ID: 9990682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
    Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
    Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoscintigraphy of metastatic breast carcinoma.
    Taylor JL; Taylor DN; Lowry C; Keeling AA; Bradwell AR; McIntosh A; Rhodes A
    Eur J Surg Oncol; 1992 Feb; 18(1):57-63. PubMed ID: 1737595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoguided surgery.
    Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
    Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.
    De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG
    Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.
    Denardo SJ; Richman CM; Goldstein DS; Shen S; Salako Q; Kukis DL; Meares CF; Yuan A; Welborn JL; Denardo GL
    Anticancer Res; 1997; 17(3B):1735-44. PubMed ID: 9179227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoimaging of human breast cancer xenografts in nude mice by using human anti-human breast cancer monoclonal antibodies.
    Sun Q; Wang S; Huang H; Yang Z; Zhu Y
    Chin Med Sci J; 1997 Jun; 12(2):80-3. PubMed ID: 11324504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancer.
    Lind P; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Omann J; Dinges HP; Boniface G
    Clin Nucl Med; 1997 Jan; 22(1):30-4. PubMed ID: 8993870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible uses of positron emission tomography in breast carcinoma].
    Römer W; Avril N; Schwaiger M
    Acta Med Austriaca; 1997; 24(2):60-2. PubMed ID: 9273807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the current status of PET in breast cancer imaging.
    Wahl RL
    Q J Nucl Med; 1998 Mar; 42(1):1-7. PubMed ID: 9646639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
    Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
    HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody].
    Ito K; Nakata K; Watanabe T; Hibi K; Kasai Y; Akiyama S; Takagi H
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):373-9. PubMed ID: 9101544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.